AI Advances in Breast Cancer Screening and Drug Development

Google Health has developed an AI-powered tool called Mammo AI that can detect breast cancer with 99% accuracy

Artificial intelligence (AI) is rapidly transforming the field of medicine, and breast cancer is no exception. AI is being used to improve breast cancer screening, develop new drugs, and personalize treatment.

AI-powered breast cancer screening

One of the most promising applications of AI in breast cancer is in screening. AI-powered tools can be used to analyze mammograms and other images of the breast to detect cancer earlier and more accurately than human radiologists. For example, a recent study found that an AI-powered tool developed by Google Health was able to detect breast cancer with 99% accuracy, compared to 87% accuracy for human radiologists.

This is significant because early detection of breast cancer is critical for improving survival rates. The earlier breast cancer is detected, the more likely it is to be successfully treated. AI-powered breast cancer screening could help to save lives by reducing the number of women who die from the disease.

In addition to screening and drug discovery, AI is also being used to personalize breast cancer treatment. AI can be used to predict how a patient will respond to different treatments, and it can also be used to create treatment plans that are tailored to the individual patient.

For example, the company Thrive Earlier Detection has developed an AI-powered tool called the ThriveRiskScore. The ThriveRiskScore can be used to predict a woman’s risk of developing breast cancer, and it can also be used to recommend personalized screening and prevention strategies.

AI-powered drug development

AI is also being used to develop new drugs for breast cancer. Pharmaceutical companies are using AI to screen millions of compounds for potential drug candidates. This process is much faster and more efficient than traditional drug discovery methods.

For example, a recent study by the University of California, San Francisco, used AI to identify a new drug candidate for breast cancer. The drug, called PF-07282672, is currently in clinical trials.

AI is also being used to personalize breast cancer treatment. AI-powered tools can be used to analyze a woman’s individual tumor profile to identify the best treatment options. This could help to improve the effectiveness of treatment and reduce the risk of side effects.

Photo of author

Cray Zephyr

Cray has a major in philosophy and likes to keep things simple. He tries to keep his opinions to himself but will never shy out of a discussion, except with chickens. A chicken always wins.